Yükleniyor... / Loading...
This study evaluates a newborn screening program to detect severe combined immunodeficiency (SCID), a serious inherited immune disorder, early in life. Newborns on the third day of life, plus a control group of patients already diagnosed with SCID without screening, were able to take part. It was conducted as a study with no assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
+11
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Screening Group: Newborn on day 3 of birth (premature and non premature) * Control group: Patients diagnosed with SCID without screening at participating centers Exclusion Criteria: * Lack of parental consent * Children whose parents are adults under guardianship, * Children without health insurance, for the screening group: * The early exit of the child from the maternity hospital